title: [Surveillance of prostate adenoma patients administering selective alpha-1a-adrenoblocker].
authors.forename: V F
authors.initials: VF
authors.lastname: Zhukov
authors.forename: M I
authors.initials: MI
authors.lastname: Vasil'chenko
authors.forename: A V
authors.initials: AV
authors.lastname: Proletarskiĭ
mesh_terms: D000236:Adenoma / Q000175:diagnosis / Q000188:drug therapy*; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D018340:Receptors, Adrenergic, alpha-1; D013449:Sulfonamides / Q000627:therapeutic use*; D000077409:Tamsulosin; D016896:Treatment Outcome
chemical_list: C547713:ADRA1A protein, human; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D000970:Antineoplastic Agents; D018340:Receptors, Adrenergic, alpha-1; D013449:Sulfonamides; D000077409:Tamsulosin